By: Gasper J. LaRosa
Last week, Chief Judge Ruschke made the attached presentation to the International Intellectual Property Association. Chief Judge Ruschke emphasized that IPR filings appear to be leveling off and that the PTAB does not invalidate patents at a rate as high as commonly believed. The presentation is data driven, and has useful information about institution rates broken down by type of proceeding and technology area.
The following two tabs change content below.
Gasper LaRosa is co-chair of Jones Day's PTAB Litigation Practice and is a leading pharmaceutical and biotechnology patent lawyer as recognized by clients and his peers. He has more than 15 years of client-focused experience litigating high-profile patent infringement cases involving pharmaceutical products, medical devices, chemical manufacturing processes, and business methods. He has tried patent cases to juries and to the bench in several federal district courts. In addition, Gasper has broad experience representing clients as lead counsel in USPTO post-grant proceedings.
Latest posts by Gasper LaRosa (see all)
- PTAB Bar Association – Thought Leader Summit Recap - December 18, 2019
- Trial Court Denies Amendment of Contentions To Add Reexam Claims Following Successful IPR - October 21, 2019
- Precedential: PTAB Considers § 314(a) Factors Even When Denying Under § 325(d) - May 13, 2019